TRIB2 regulates the expression of miR-33a-5p through the ERK/c-Fos pathway to affect the imatinib resistance of chronic myeloid leukemia cells

Chronic myeloid leukemia (CML) is a hematological disease, and imatinib (IM) resistance represents a major problem for its clinical treatment. In the present study, the role of tribbles pseudokinase 2 (TRIB2) in IM resistance of CML and the possible mechanism were investigated. It was found that TRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hang, Li, Youjie, Wang, Xiao, Zhou, Xue, Rong, Simin, Liang, Dongmin, Sun, Guangbin, Cao, Huizhen, Sun, Hongfang, Wang, Ranran, Yan, Yunfei, Xie, Shuyang, Sun, Yunxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973951/
https://www.ncbi.nlm.nih.gov/pubmed/35302171
http://dx.doi.org/10.3892/ijo.2022.5339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973951/
https://www.ncbi.nlm.nih.gov/pubmed/35302171
http://dx.doi.org/10.3892/ijo.2022.5339

Ejemplares similares